Rapid TNFR1-dependent lymphocyte depletion in vivo with a selective chemical inhibitor of IKKβ
Rapid TNFR1-dependent lymphocyte depletion in vivo with a selective chemical inhibitor of IKKβ
复制标题
DOI:
10.1182/blood-2005-09-3852
复制
发表时间:
2006-06-01
期刊:
影响因子:
20.3
通讯作者:
Fraser, Christopher C.
中科院分区:
文献类型:
--
作者:
Nagashima, Kumiko;Sasseville, Vito G.;Fraser, Christopher C.
The transcription factor NF-kappa B plays a central role in regulating inflammation and apoptosis, making it a compelling target for drug development. We identified a small molecule inhibitor (ML120B) that specifically inhibits IKK beta, an Ikappa-B kinase that regulates NF-kappa B. IKK beta and NF-kappa B are required in vivo for prevention of TNF alpha-mediated apoptosis. ML120B sensitized mouse bone marrow progenitors and granulocytes, but not mature B cells to TNF alpha killing in vitro, and induced apoptosis in vivo in the bone marrow and spleen within 6 hours of a single oral dose. In vivo inhibition of IKK beta with ML120B resulted in depletion of thymocytes and B cells in all stages of development in the bone marrow but did not deplete granulocytes. TNF receptor-deficient mouse thymocytes and B cells were resistant to ML120B-induced depletion in vivo. Surprisingly, surviving bone marrow granulocytes expressed TNFR1 and TNFR2 after dosing in vivo with ML120B. Our results show that inhibition of IKK beta with a small molecule in vivo leads to rapid TNF-dependent depletion of T and B cells. This observation has several implications for potential use of IKK beta inhibitors for the treatment of inflammatory disease and cancer.